Clinical trial

Comparing the Efficacy of Periarticular Bone Structure in Patients Treated With Either Tocilizumab or Tumor Necrosis Factor Blockers

NCT02778789

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Tocilizumab Normalized identity: tocilizumabView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention TNF-alpha Inhibitor Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Comparing the Efficacy of Periarticular Bone Structure in Patients Treated With Either Tocilizumab or Tumor Necrosis Factor Blockers

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2015-10-01

PhaseN/A

Conditions

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Interventions

TocilizumabDRUG · verified · RxNorm: tocilizumab

TNF-alpha InhibitorDRUG

Sponsors & collaborators

University of Erlangen-Nürnberg Medical Schoollead sponsor

Mapped research locations

ErlangenGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02778789 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.